Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(12/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(12/week)
News
United States
(499/week)
Manufacturing
(342/week)
Energy
(283/week)
Technology
(381/week)
Alternative Energy
(143/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Fatty liver
Mar 05, 2018
Galmed Pharmaceuticals to Report Full Year and Fourth Quarter 2017 Financial Results and Provide Business Update on Tuesday, March 13
Mar 02, 2018
Galmed Pharmaceuticals to Participate in Investor Conferences in March
Feb 14, 2018
Galmed Announces ARRIVE Study Data
Feb 08, 2018
Galmed Pharmaceuticals to Provide Corporate Update at the LEERINK Partners 7th Annual Global Healthcare Conference
Feb 07, 2018
Galmed Granted "Preferred Technological Enterprise" Status Which may Provide the Company With Significant Financial Benefits
Jan 10, 2018
TARGET PharmaSolutions to advance NASH Research through new collaboration
Jan 04, 2018
Spitfire Pharma's SP-1373 outscored semaglutide and elafibranor in a biopsy-proven translational mouse model of non-alcoholic steatohepatitis (NASH)
Nov 30, 2017
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
Nov 27, 2017
Galmed Pharmaceuticals to Present at HEP DART 2017 Meeting
Nov 27, 2017
FDA Clearance For Perspectum Diagnostics' LiverMultiScan(TM) Means More Patients Can Benefit From Access To State-Of-The-Art Non-Invasive Diagnostic Aid For Liver Disorders
Nov 21, 2017
NAFLD/NASH Diagnosis is Unexpected to People Not Aware of This Rising Epidemic
Nov 07, 2017
Galmed Pharmaceuticals to Provide Corporate Overview at the Stifel 2017 Healthcare Conference
Nov 01, 2017
Galmed Pharmaceuticals to Report Third Quarter Financial Results on Thursday, November 9th
Oct 24, 2017
Viking Therapeutics Presents Results from In Vivo Study of VK2809 in Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Oct 20, 2017
Prometic presents PBI-4050 and PBI-4547 in Vivo Data at American Association for the Study of Liver Diseases (AASLD) Meeting
Oct 20, 2017
Clinical Data To Be Presented At AASLD 2017 Shows Single Revita DMR Procedure Elicits Sustained Improvements In Hepatic Indices In Type 2 Diabetes Patients Through 12 Months
Oct 19, 2017
Galmed Pharmaceuticals to Host Key Opinion Leader Meeting on Non-Alcoholic Steato-Hepatitis (NASH)
Oct 19, 2017
NGM Bio Provides Update On NGM282 In NASH
Oct 19, 2017
Boehringer Ingelheim partners with TARGET PharmaSolutions to Progress NASH Research
Oct 16, 2017
Noninvasive PROMETHEUS® FIBROSpect® NASH Test Measures Severity of Liver Fibrosis
‹‹
Page 3
››
Latest News
May 17, 2024
Fonon Corporation Highlights Its Laser Technology for Cutting Reflective Metals in Sanitary Equipment...
May 17, 2024
Exchange Income Corporation Announces May 2024 Dividend
May 17, 2024
Torus Celebrates Grand Opening of Manufacturing Facility With Advanced Technology Demonstrations and...
May 17, 2024
nVent Announces Share Repurchase Authorization
May 17, 2024
nVent Announces Quarterly Cash Dividend
May 17, 2024
American Rebel to Exhibit at the 153rd NRA Annual Meeting in Dallas, Texas
May 17, 2024
EnerSys Secures Energy Storage Product of the Year Award
May 17, 2024
Cyber Flex Launches: Transforming Vaping with Superior Technology and Style
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events